Not only this approach can improve statistical power by cumulating the effects of multiple variants but also offers unique interpretation of the protein as the potential target of the alteration in binding of a corresponding TF, highlighting the distinct mechanisms regulated by specific subsets of RCC related variants. The gene discussed is TF; the disease is renal cell carcinoma.